Institut Mérieux announces the sale of ABL Inc.

A sale and purchase agreement for the acquisition of ABL Inc. has been signed with EW Healthcare Partners, an investor in the healthcare sector, active in Europe and the United States.

Already active in research and contract biomanufacturing (CDMO), EW Healthcare Partners will provide ABL Inc. new resources to ensure its long-term development.

‌As part of the sale, the ABL Inc. teams and the Rockville site will be maintained. They will be able to continue to provide their expertise to the US government and biotech companies with which they have worked for many years.